Name: GSM2212086 - Doxorubicin2 vs Control2, 7 week post treatment, reverse labelling
Creator: Saket Lab
License: https://www.ncbi.nlm.nih.gov/geo/info/disclaimer.html

GSM2212086 - Doxorubicin2 vs Control2, 7 week post treatment, reverse labelling | seqout